Health
Preventing and Treating Cardiotoxicity in Patients With Breast Cancer Involves Aggressive Monitoring, Management Strategies – Cancer Network
Mandar Aras, MD, PhD, discussed the management and prevention of cardiotoxicity in patients receiving systemic therapy for breast cancer at the 38th Annual Miami…
Cardiac dysfunction is a prominent concern in patients receiving therapy for breast cancer, especially those with HER2-positive disease who may receive targeted therapies and have a history of prior anthracyclines exposure.
In a presentation at the 38th Annual Miami Breast Cancer Conference, hosted by Physicians Education Resource®, LLC, Mandar Aras, MD, PhD, of the University of California San Francisco, discussed best strategies for treating these patients, which includes consistent monitoring…
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
Noosa News8 hours agoNSW farmer calls for hunting buffer zones after bullets hit property
-
General21 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
General14 hours agoFrench far-right supporters rally against Le Pen conviction in Paris